Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2025-12-25 @ 3:45 AM
NCT ID: NCT02109302
Eligibility Criteria: Inclusion Criteria: 1. . Patients (index cases ) Prospective and retrospective cases * Man aged over 18 years * signing the informed consent * Presenting primary PE * have an affiliation to a social security system 2. . Related * Male or female over 18 years * be related to the index case * signing the informed consent * have an affiliation to a social security system Non Inclusion Criteria: 1. . Patients ( index case ) : * Be aged under 18 * have known genetic variations that predispose or can promote psychological disorders that can lead to PE ( eg: Kallman 's Syndrome , micropenis , testicular dysgenesis , Klinfelter syndrome, Leydig cell hypoplasia ) * have had psycho- social and psycho- traumatic factors in childhood * Inability to receive clear information on the protocol * Person deprived of liberty by judicial or administrative decision * Major Person subject of legal protection or unable to consent * Refusal to be informed of an abnormality detected after genetic testing * History of allergies to lidocaine or other anesthetic agent used during puncture or blood sample 2. . Related : * Age \<18 years * Inability to receive clear information about the protocol . Unable to participate in the entire study. * No coverage by the social security system * Absence of signature of consent or refusal of the related party * Person deprived of liberty by judicial or administrative decision * Major Person subject of legal protection or unable to consent * Refusal to be informed of a genetic abnormality detected * History of allergies to lidocaine or other anesthetic agent used during puncture or blood sample
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT02109302
Study Brief:
Protocol Section: NCT02109302